Chin Mark
Insider CIK 1734389 · ITRM Director · IMRA Director, 10% owner · HARP Director, 10% owner · PYXS Director · IRON Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRON Disc Medicine, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 6,212 | — | $0 | 6,212 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 1,016 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 3,214 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,300 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,033 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 13,224 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-03-08 | 2024-03-11 | 424 | — | $0 | 13,224 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-01-01 | 2024-01-03 | 1,072 | — | $0 | 12,801 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-11-27 | 2023-11-28 | 5,000 | — | $0 | 11,729 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-10-01 | 2023-10-02 | 3,035 | — | $0 | 6,729 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-07-01 | 2023-07-06 | 18,656 | — | $0 | 36,941 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-06-15 | 2023-06-15 | 15,853 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-06-15 | 2023-06-15 | 15,853 | — | $0 | 18,306 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2023-06-09 | 2023-06-09 | 7,136 | — | $0 | 7,136 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-04-01 | 2023-04-04 | 18,285 | — | $0 | 18,285 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 36,798 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 32,142 | $1.40 | $45.0K | 32,142 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-15 | 2022-06-17 | 237,795 | $0.01 | $2.4K | 237,795 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2022-04-21 | 2022-04-25 | 1,745,761 | $3.05 | $5.32M | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2022-03-31 | 2022-04-04 | 66,831 | — | $0 | 66,831 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion deriv | 2021-10-13 | 2021-10-15 | 9,114,109 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion | 2021-10-13 | 2021-10-15 | 1,433,261 | — | $0 | 1,433,261 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | P Buy | 2021-10-13 | 2021-10-15 | 312,500 | $16.00 | $5.00M | 1,745,761 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2021-10-07 | 2021-10-12 | 42,191 | — | $0 | 42,191 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2021-07-16 | 2021-07-28 | 1,333,333 | $6.00 | $8.00M | 2,344,072 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2021-06-29 | 2021-06-30 | 7,728 | — | $0 | 7,728 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 36,798 | — | $0 | 36,798 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 3,017 | — | $0 | 3,017 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 2,438 | — | $0 | 2,438 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 10,167 | — | $0 | 10,167 | SEC↗ |
| ITRM Iterum Therapeutics plc | J Other | 2020-07-28 | 2021-03-03 | 11,857 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2020-07-01 | 2020-07-02 | 5,703 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2020-07-01 | 2020-07-02 | 5,703 | — | $0 | 11,857 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 3,017 | — | $0 | 3,017 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 10,167 | — | $0 | 10,167 | SEC↗ |
| ITRM Iterum Therapeutics plc | J Other deriv | 2020-04-07 | 2020-04-09 | 0 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | J Other | 2020-04-07 | 2020-04-09 | 1,089,903 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 8,611,110 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 187,500 | $16.00 | $3.00M | 1,554,558 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 1,367,058 | — | $0 | 1,367,058 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $1900000.00 | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-17 | 2019-12-17 | 12,476 | $16.83 | $210.0K | 2,572,359 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-16 | 2019-12-17 | 13,080 | $17.02 | $222.6K | 2,584,835 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-13 | 2019-12-17 | 11,002 | $17.21 | $189.3K | 2,597,915 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-10 | 2019-12-10 | 131,696 | $16.91 | $2.23M | 2,608,917 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-09 | 2019-12-10 | 77,316 | $18.12 | $1.40M | 2,740,613 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-09 | 2019-12-10 | 26,438 | $18.30 | $483.8K | 2,817,929 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-12-06 | 2019-12-10 | 47,752 | $19.15 | $914.5K | 2,844,367 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 5,703 | — | $0 | 5,703 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,167 | — | $0 | 10,167 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,720,698 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 742,850 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 428,571 | $14.00 | $6.00M | 2,892,119 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 742,850 | — | $0 | 2,463,548 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,720,698 | — | $0 | 1,720,698 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-02-07 | 2019-03-29 | 6,071 | — | $0 | 6,071 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2018-12-19 | 2019-02-14 | 20,335 | — | $0 | 20,335 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2018-11-09 | 2019-02-14 | 742,850 | — | $0 | 742,850 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-10-30 | 2018-11-01 | 58,000 | $6.10 | $353.8K | 1,089,903 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-06-01 | 248,721 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-06-01 | 445,576 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-06-01 | 337,606 | $13.00 | $4.39M | 1,031,903 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-06-01 | 445,576 | — | $0 | 445,576 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-06-01 | 248,721 | — | $0 | 694,297 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |